Australian Gonococcal Surveillance Programme 1 January to 31 March 2017

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Invasive pneumococcal disease surveillance, 1 January to 31 March 2016.

The number of notified cases of invasive pneumococcal disease (IPD) in the 1st quarter of 2016 was substantially fewer than the previous quarter and marginally less than the number of notified cases in the 1st quarter of 2015. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the...

متن کامل

National Notifiable Diseases Surveillance System, 1 January to 31 March 2017.

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 67,031 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 January to 31 March 2016 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3. Table 1: Reporting of notifiable diseases by jurisdic...

متن کامل

HIV surveillance, 1 January to 31 March 2014.

National surveillance for HIV infection is coordinated by the Kirby Institute, in collaboration with state and territory health authorities and the Australian Government Department of Health. Cases of HIV infection are notified to the National HIV Registry on the first occasion of diagnosis in Australia, by either the diagnosing laboratory (Australian Capital Territory, New South Wales, Tasmani...

متن کامل

Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016 .

The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on sensitivity to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). The antibiotics are penicillin, ceftriaxone, azithromycin and ciprofloxacin, which are current or potential agents used for the treatment of gonorrhoea....

متن کامل